Mehrdad Hashemi

8.6k total citations · 3 hit papers
356 papers, 5.7k citations indexed

About

Mehrdad Hashemi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mehrdad Hashemi has authored 356 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Molecular Biology, 110 papers in Cancer Research and 45 papers in Oncology. Recurrent topics in Mehrdad Hashemi's work include Cancer-related molecular mechanisms research (69 papers), MicroRNA in disease regulation (59 papers) and Circular RNAs in diseases (55 papers). Mehrdad Hashemi is often cited by papers focused on Cancer-related molecular mechanisms research (69 papers), MicroRNA in disease regulation (59 papers) and Circular RNAs in diseases (55 papers). Mehrdad Hashemi collaborates with scholars based in Iran, United States and Türkiye. Mehrdad Hashemi's co-authors include Maliheh Entezari, Kiavash Hushmandi, Afshin Taheriazam, Sepideh Mirzaei, Ali Zarrabi, Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Shokooh Salimimoghadam, Saeed Samarghandian and Alan Prem Kumar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Brain Research.

In The Last Decade

Mehrdad Hashemi

330 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging role of exosomes in cancer progression and tumor microenvironment remodeling

2022 393 citations Mahshid Deldar Abad Paskeh, Maliheh Entezari et al. profile →
(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy

2023 129 citations Ali Zarrabi, Afshin Taheriazam et al. profile →
Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies

2025 64 citations Najma Farahani, Maliheh Entezari et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mehrdad Hashemi Iran	37	3.1k	1.6k	701	626	551	356	5.7k
Jianwen Liu China	48	3.2k 1.0×	1.5k 0.9×	744 1.1×	532 0.8×	495 0.9×	226	6.5k
Dongming Xing China	43	3.3k 1.1×	1.1k 0.7×	760 1.1×	488 0.8×	370 0.7×	220	6.7k
Kiavash Hushmandi Iran	50	4.1k 1.3×	2.5k 1.5×	1.1k 1.5×	830 1.3×	660 1.2×	197	6.8k
Jing Chen China	41	3.0k 0.9×	1.3k 0.8×	576 0.8×	414 0.7×	331 0.6×	176	6.1k
Xue Wang China	41	3.2k 1.0×	1.5k 0.9×	578 0.8×	376 0.6×	503 0.9×	323	6.7k
Fátima Baltazar Portugal	47	3.7k 1.2×	3.0k 1.8×	1.3k 1.9×	539 0.9×	725 1.3×	174	6.9k
Xizhong Shen China	47	3.9k 1.2×	1.4k 0.8×	799 1.1×	923 1.5×	414 0.8×	181	6.7k
Yang Li China	47	4.5k 1.4×	1.7k 1.0×	1.2k 1.6×	520 0.8×	435 0.8×	276	8.1k
Ling Dong China	40	2.3k 0.7×	956 0.6×	740 1.1×	557 0.9×	357 0.6×	155	4.8k
Zhiping Li China	44	3.9k 1.2×	1.2k 0.7×	1.8k 2.5×	408 0.7×	529 1.0×	174	7.1k

Countries citing papers authored by Mehrdad Hashemi

Since Specialization

Citations

This map shows the geographic impact of Mehrdad Hashemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Hashemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Hashemi more than expected).

Fields of papers citing papers by Mehrdad Hashemi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehrdad Hashemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Hashemi. The network helps show where Mehrdad Hashemi may publish in the future.

Co-authorship network of co-authors of Mehrdad Hashemi

This figure shows the co-authorship network connecting the top 25 collaborators of Mehrdad Hashemi. A scholar is included among the top collaborators of Mehrdad Hashemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehrdad Hashemi. Mehrdad Hashemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farahani, Najma, Mina Alimohammadi, Noushin Nabavi, et al.. (2025). Sulforaphane in alternative cancer chemotherapy: From carcinogenesis suppression to drug resistance reversal. Results in Chemistry. 13. 102059–102059. 6 indexed citations

Safari, Majid, Najma Farahani, Mina Alimohammadi, et al.. (2025). Metastasis and chemoresistance in breast cancer: Crucial function of ZEB1/2 proteins. Pathology - Research and Practice. 267. 155838–155838. 7 indexed citations

Mahdavinezhad, Ali, et al.. (2025). Role of hsa_Circ_0001821 in Colorectal Cancer Pathogenesis and Response to 5-Fluorouracil through miR-203a-3p/FGF-2 Axis. PubMed. 29(1). 82–89. 1 indexed citations

Babashah, Sadegh, et al.. (2025). Botox-A induced apoptosis and suppressed cell proliferation in fibroblasts pre-treated with breast cancer exosomes. Molecular and Cellular Probes. 79. 102007–102007. 3 indexed citations

Peymani, Maryam, et al.. (2024). The Prospective role of lapatinib as an adjuvant therapy in prevalent cancers: Insights from in silico analysis targeting EGFR and HER2. Molecular and Cellular Probes. 78. 101985–101985.

Li, Dabing, Waqar Ahmad, Maliheh Entezari, et al.. (2024). Discovery of PELATON links to the INHBA gene in the TGF-β pathway in colorectal cancer using a combination of bioinformatics and experimental investigations. International Journal of Biological Macromolecules. 270. 132239–132239. 9 indexed citations

Gholamzad, Mehrdad, et al.. (2024). Exploring the virome: An integral part of human health and disease. Pathology - Research and Practice. 260. 155466–155466. 7 indexed citations

Amiri, Shayan, Mazaher Maghsoudloo, Mina Alimohammadi, et al.. (2024). The impact of exosomes on bone health: A focus on osteoporosis. Pathology - Research and Practice. 263. 155618–155618. 3 indexed citations

Aminian, Amir, et al.. (2024). Unraveling the molecular landscape of osteoarthritis: A comprehensive review focused on the role of non-coding RNAs. Pathology - Research and Practice. 260. 155446–155446. 5 indexed citations

10.

Hushmandi, Kiavash, Seyed Hassan Saadat, Mehdi Raei, et al.. (2024). The science of exosomes: Understanding their formation, capture, and role in cellular communication. Pathology - Research and Practice. 259. 155388–155388. 14 indexed citations

11.

Peymani, Maryam, et al.. (2023). Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in Breast, colorectal and gastric cancers. Gene. 892. 147867–147867. 22 indexed citations

12.

Hashemi, Mehrdad, et al.. (2023). Combination of natural scaffolds and conditional medium to induce the differentiation of adipose-derived mesenchymal stem cells into keratocyte-like cells and its safety evaluation in the animal cornea. Tissue and Cell. 82. 102117–102117. 12 indexed citations

13.

Taheriazam, Afshin, Mohammad Arad Zandieh, Sepideh Mirzaei, et al.. (2023). Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis. Journal of Controlled Release. 354. 503–522. 63 indexed citations

14.

Mahdavinezhad, Ali, Rezvan Najafi, Saeid Afshar, et al.. (2023). Highlighting functions of apoptosis and circular RNAs in colorectal cancer. Pathology - Research and Practice. 248. 154592–154592. 4 indexed citations

15.

Hashemi, Mehrdad, et al.. (2023). Expression alteration of Neuroligin family gene in attention deficit and hyperactivity disorder and autism spectrum disorder. Research in Developmental Disabilities. 139. 104558–104558. 3 indexed citations

16.

Hashemi, Mehrdad, et al.. (2020). Co-expression of HOTAIR long noncoding RNA and Tbx3 transcription factor in breast cancer tissues. Gene Reports. 20. 100796–100796. 1 indexed citations

17.

Heiat, Mohammad, et al.. (2010). CLONING AND EXPRESSION OF N-TERMINAL REGION OF IPAD FROM SHIGELLA DYSENTERIAE IN E. COLI. Journal of paramedical sciences.. 1(4). 12–17. 2 indexed citations

18.

Biazar, Esmaeil, et al.. (2010). HARVESTING EPITHELIAL CELL SHEET BASED ON THERMO- SENSITIVE HYDROGEL. Journal of paramedical sciences.. 1(3). 27–33. 2 indexed citations

19.

Hashemi, Mehrdad, et al.. (2009). Quantitative real-time PCR technique for rapid diagnosis of trisomy 21. Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch. 19(2). 93–96. 1 indexed citations

20.

Hashemi, Mehrdad, et al.. (2009). EXPERIMENTAL STUDY OF CELL DEATH IN LYMPHOID TISSUES OF SPF CHICKENS WITH AVIAN INFLUENZA VIRUS (H9N2) INFECTION. Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch. 19(2). 81–86.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact